Search research articles
Contact Us
Filters
Showing results (171-180 of 179) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 179 results.
Journal for Immunotherapy of Cancer
|
October 24, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer
Nicolas Zhou, Cheuk H Leung, William N William, et al.
Nature Communications
|
November 18, 2021
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Ming Chen, Runzhe Chen, Ying Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2025
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B)
James Chih-Hsin Yang, Mengzhao Wang, Ludovic Doucet, et al.
Cancer Cell
|
May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception
Bo Zhu, Pingjun Chen, Muhammad Aminu, et al.
The Lancet. Digital Health
|
June 2, 2023
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
Maliazurina B Saad, Lingzhi Hong, Muhammad Aminu, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Nature
|
February 27, 2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 179) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 179 results.
Journal for Immunotherapy of Cancer
|
October 24, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer
Nicolas Zhou, Cheuk H Leung, William N William, et al.
Nature Communications
|
November 18, 2021
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Ming Chen, Runzhe Chen, Ying Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2025
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B)
James Chih-Hsin Yang, Mengzhao Wang, Ludovic Doucet, et al.
Cancer Cell
|
May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception
Bo Zhu, Pingjun Chen, Muhammad Aminu, et al.
The Lancet. Digital Health
|
June 2, 2023
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
Maliazurina B Saad, Lingzhi Hong, Muhammad Aminu, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Nature
|
February 27, 2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 18